Quote:
Originally Posted by cral12
I don't typically dive into indiviual stocks, but do follow stocks I'm interested in, loosly.
The emerging space of companies focused on psychedelics (for mental health purposes and perhaps eventually for wellbeing; I work in pain management/palliative care and believe in the immense potential of these, therapeutically).
Probably obviously very speculative and volatile at this point given their legal status, but the tide appears to be changing with that respect...
Anyway, anyone else interested in this space and/or have insight?
Some of the companies:
NUMI, MMED (the main 2 I'm interested in)
TRIP, SHRM
Some info:
https://candlr.com/psychedelic-sector/ |
Super bummed I didn't follow my instincts and research on NUMI & MMED.
My goal was to get MMED below 50 cents and NUMI 25 cents. One dipped to around 48 cents. The other to 19 cents. Then I got cold feet, so I never did get in! Ugh. Yesterday, MMED approaching 5$, Numi approaching 1.50$.
Good to see at least some CPers got on MMED.